SHARE

Sponsored Content

This article is part of a paid Content Partnership with the advertiser, Town of Greenburgh. Daily Voice has no involvement in the writing of the article and the statements and opinions contained in it are solely those of the advertiser.

To learn more about Content Partnerships, click here.

Time Cites Tarrytown-Greenburgh As One Of Nation's 'Most Genius Places'

GREENBURGH, N.Y. -- In 1994 former Governor Mario Cuomo attended a press conference at Greenburgh Town Hall and lauded the town for its work in helping CIBA, a multi-national pharmaceuticals company, stay in town. Today, the 287 Corridor between Greenburgh and Tarrytown has been named one of the brightest in the country, according to Times Magazine, where the municipality was ranked 40th.

The Tarrytown-Greenburgh corridor has been ranked the 40th 'Most Genius Place In America' by Times Magazine.

The Tarrytown-Greenburgh corridor has been ranked the 40th 'Most Genius Place In America' by Times Magazine.

Photo Credit: DV File

"Since that time we have tried hard to attract many additional bio tech companies to Greenburgh," said Town Supervisor Paul Feiner. "We’ve been successful by creating two major bio tech corridors in the unincorporated section of Greenburgh: Tarrytown and south of downtown Ardsley. Greenburgh has become the bio tech capital of our region and we’re proud of that distinction," he said.

Regeneron, on of the major bio tech companies located in the unincorporated Greenburgh section of Tarrytown, has become one of the leading bio tech companies in the world. The company's growth has resulted in the planning of a significant expansion in Greenburgh this coming year. 

Click here to view the complete list.

This article is part of a paid Content Partnership with the advertiser, Town of Greenburgh. Daily Voice has no involvement in the writing of the article and the statements and opinions contained in it are solely those of the advertiser.

To learn more about Content Partnerships, click here.

SCROLL TO NEXT ARTICLE